A Kentucky lawmaker has filed a new bill that would strengthen oversight of compounded drugs, including weight loss ...

Novo Nordisk is suing a Shrewsbury doctor who sells a cheaper compounded medicine version of its popular Ozempic and Wegovy ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

Novo Nordisk’s CEO says compounded GLP-1 knockoffs sourced from overseas ingredients could endanger patients and undermine FDA oversight as legal battle escalates.

After years of wide-open compounding, regulators say they’re ready to enforce limits and restore control over the ...

GLP-1 medications have changed the conversation around weight management and metabolic health. When prescribed appropriately, ...

Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these ...

BALTIMORE — Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy labs, sickened some 8,000 or more Marylanders a year by 2024. The Food and ...

Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs.

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss ...

Julia Ingram is a data journalist for CBS News Confirmed. She uses data analysis and computation to cover misinformation, AI and social media. Readdy, who has struggled with her weight for most of her ...

If you knew a medicine wasn’t regulated or reviewed by the U.S. Food and Drug Administration, would you still be willing to take it? My guess is that most people wouldn’t willingly put an unknown ...